CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-14 | HIGGINS JOHN L Director | Option exercise · Stock Options (Right to Buy) | −4,000 | 12,000 | ||
| 2024-05-01 | Klimovsky Judith V Director | Grant or award | +680 | 680 | ||
| 2024-05-01 | Klimovsky Judith V Director | Grant or award · Stock Option (Right to Buy) | +1,610 | 1,610 | ||
| 2024-04-03 | Bohnen Shane SVP - General Counsel | Option exercise | +2,259 | 2,394 | ||
| 2024-04-03 | Bohnen Shane SVP - General Counsel | Shares withheld for taxes | −747 | $67.87 | $51K | 1,647 |
| 2024-04-03 | Bohnen Shane SVP - General Counsel | Option exercise · Restricted Stock Units | −2,259 | 4,519 | ||
| 2024-03-07 | Nusse Roeland Director | Sale | −10,400 | $76.98 | $801K | 43,097 |
| 2024-02-01 | Geist William PRESIDENT, PROTEIN SCIENCES | Shares withheld for taxes | −1,111 | $68.54 | $76K | 7,759 |
| 2024-02-01 | McManus Matthew President - DGS | Grant or award · Restricted Stock Units | +2,888 | 2,888 | ||
| 2024-02-01 | McManus Matthew President - DGS | Grant or award · Restricted Stock Units | +13,861 | 13,861 | ||
| 2024-02-01 | McManus Matthew President - DGS | Grant or award · Stock Option (Right to Buy) | +7,951 | 7,951 | ||
| 2024-02-01 | McManus Matthew President - DGS | Grant or award · Stock Option (Right to Buy) | +15,902 | 15,902 | ||
| 2024-02-01 | Kelderman Kim Chief Operating Officer | Grant or award · Restricted Stock Units | +9,423 | 9,423 | ||
| 2024-02-01 | Kelderman Kim Chief Operating Officer | Grant or award · Stock Options (Right to Buy) | +25,945 | 25,945 | ||
| 2024-02-01 | Kelderman Kim Chief Operating Officer | Grant or award · Stock Options (Right to Buy) | +51,890 | 51,890 | ||
| 2023-12-19 | Hippel James CFO | Option exercise | +47,289 | $31.26 | $1.5M | 104,850 |
| 2023-12-19 | Hippel James CFO | Shares withheld for taxes | −32,966 | $77.42 | $2.6M | 71,884 |
| 2023-12-19 | Hippel James CFO | Option exercise · Stock Options (Right to Buy) | −47,289 | 141,867 | ||
| 2023-11-01 | Geist William PRESIDENT, PROTEIN SCIENCES | Grant or award · Restricted Stock Units | +19,823 | 19,823 | ||
| 2023-11-01 | Geist William PRESIDENT, PROTEIN SCIENCES | Grant or award · Restricted Stock Units | +19,857 | 19,857 |
Page 17 of 32 · 626 trades